tiprankstipranks
Advertisement
Advertisement

HK:1011 Stock Latest News

China NT Pharma Seeks Shareholder Approval for Major Debt-to-Equity Share Subscriptions
Company AnnouncementsChina NT Pharma Seeks Shareholder Approval for Major Debt-to-Equity Share Subscriptions
5d ago
1011
China NT Pharma Schedules Board Meeting to Review Interim Results and Dividend
PremiumCompany Announcements
China NT Pharma Schedules Board Meeting to Review Interim Results and Dividend
5d ago
1011
China NT Pharma Advances Medical Device Integration and Debt Restructuring
PremiumCompany Announcements
China NT Pharma Advances Medical Device Integration and Debt Restructuring
15d ago
1011
China NT Pharma Further Delays Circular on Loan Capitalisation Plan
PremiumCompany Announcements
China NT Pharma Further Delays Circular on Loan Capitalisation Plan
15d ago
1011
China NT Pharma Delays Shareholder Circular on Loan Capitalisation
PremiumCompany Announcements
China NT Pharma Delays Shareholder Circular on Loan Capitalisation
1M ago
1011
China NT Pharma Proposes New Auditor CCTH CPA After Moore’s Retirement
PremiumCompany AnnouncementsChina NT Pharma Proposes New Auditor CCTH CPA After Moore’s Retirement
1M ago
1011
China NT Pharma Names New CEO as Leadership Shifts to Next Generation
Premium
Company Announcements
China NT Pharma Names New CEO as Leadership Shifts to Next Generation
1M ago
1011
China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions
Premium
Company Announcements
China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions
1M ago
1011
China NT Pharma to Capitalise Debts via Major Share Issue to Connected Creditors
PremiumCompany Announcements
China NT Pharma to Capitalise Debts via Major Share Issue to Connected Creditors
2M ago
1011
China NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
PremiumCompany Announcements
China NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
2M ago
1011
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
PremiumCompany Announcements
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
2M ago
1011
China NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
PremiumCompany Announcements
China NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
3M ago
1011
China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
PremiumCompany AnnouncementsChina NT Pharma Discloses Governance Dispute Behind Director’s Resignation
3M ago
1011
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
Premium
Company Announcements
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
3M ago
1011
China NT Pharma details board and committee structure
Premium
Company Announcements
China NT Pharma details board and committee structure
3M ago
1011
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
PremiumCompany Announcements
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
3M ago
1011
China NT Pharma Reshapes Audit Oversight with New Independent Director
PremiumCompany Announcements
China NT Pharma Reshapes Audit Oversight with New Independent Director
3M ago
1011
China NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
PremiumCompany Announcements
China NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
4M ago
1011
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
PremiumCompany Announcements
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
4M ago
1011
China NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
PremiumCompany AnnouncementsChina NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
4M ago
1011
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
Premium
Company Announcements
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
5M ago
1011
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
Premium
Company Announcements
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
5M ago
1011

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >